[link removed]

Dear Team,

Last Friday, the U.S. Supreme Court announced that mifepristone—one of two drugs used in medication abortion—will remain available for now while the case seeking to revoke the Food and Drug Administration (FDA)'s approval of the drug proceeds.

This is a huge relief for millions of Americans, but the fight is far from over. We'll need you with us as we continue to pursue every legal avenue to ensure attempts to further restrict abortion access do not succeed. [[link removed]]

DONATE NOW [[link removed]]

"For now, providers and patients have the assurance that mifepristone is available and remains an FDA approved drug. But we shouldn’t even be here," said Nancy Northup, president and CEO of the Center for Reproductive Rights.

"This case should have been thrown out way before it got to the Supreme Court."

The intent of the lawsuit has always been to ban medication abortion for every person in the U.S.—and it is part of the larger agenda of anti-abortion extremists to ban all abortion care nationwide. It is going to take all of us, together, to fight forward for our essential reproductive rights. [[link removed]]

You can read more about this update here. [[link removed]] We will share more as the case continues.

Center for Reproductive Rights

DONATE NOW [[link removed]]

[link removed] [[link removed]] [link removed] [[link removed]] [link removed] [[link removed]]
reproductiverights.org [[link removed]]
The Center for Reproductive Rights uses the power of law to advance
reproductive rights as fundamental human rights around the world.
© Center for Reproductive Rights

Center for Reproductive Rights
199 Water St.
New York, NY 10038
United States
unsubscribe: [link removed]